Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Rare Earth/Strategic Metals (REMX) vs Tilray Brands Inc (TLRY) Price & Performance

VanEck Rare Earth/Strategic MetalsTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

VanEck Rare Earth/Strategic Metals vs Tilray Brands Inc — how do they compare? VanEck Rare Earth/Strategic Metals trades at $71.1, while Tilray Brands Inc trades at $4.19 (market cap $524.07M). The key difference: VanEck Rare Earth/Strategic Metals is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

REMXTLRY
Sector
Sector/ThematicHealth
52-Week High
$109.53$21.00
52-Week Low
$49.22$4.23
Market Cap
$524.07M
Enterprise Value
$621.22M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Rare Earth/Strategic Metals

REMX, the VanEck Rare Earth and Strategic Metals ETF, trades at $69.85, down 3.88% amid bearish technical signals. The ETF faces selling pressure with 13 bearish moving average signals against zero bullish, though oscillators show some buying opportunity with RSI readings in oversold territory. Recent news highlights ongoing geopolitical tensions around rare earth supply chains, with China's export controls and US efforts to secure critical minerals driving volatility in the sector.

The ETF offers exposure to 38 global rare earth companies but carries high volatility (~50% annualized) and significant China concentration risk. While strategic metals demand remains strong for technology and defense applications, REMX is best suited as a satellite holding for aggressive portfolios due to its specialized nature and geopolitical sensitivities.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.

The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About VanEck Rare Earth/Strategic Metals

REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.

Read more on REMX

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY